Summary & Overview
CPT 43201: Esophagogastroduodenoscopy with Submucosal Injection
CPT code 43201 denotes a flexible upper endoscopy with one or more submucosal injections into the esophagus. This procedure is used for targeted delivery of therapeutic agents or lifting solution beneath the mucosal layer for diagnostic or treatment purposes. Nationally, the code matters for accurate capture of endoscopic therapeutic services, appropriate allocation of facility and professional fees, and consistent reporting for clinical and quality monitoring.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for esophageal submucosal injections, common sites of service, and the service type. The publication also presents payer coverage touchpoints and common modifiers used with endoscopic procedures, practical billing considerations, and benchmarking context for utilization and reimbursement where available. Data not available in the input will be noted where applicable.
This summary equips clinicians, coders, and policy analysts with a clear understanding of what CPT code 43201 represents, why it is relevant to procedural billing and reporting, and what elements to review when reconciling clinical documentation with claims.
Billing Code Overview
CPT code 43201 describes an endoscopic procedure in which the provider inserts a flexible endoscope through the mouth and into the esophagus and performs one or more submucosal injections into the tissue beneath the mucous membrane. This service is a diagnostic/therapeutic upper endoscopy procedure focused on delivering injections to the esophageal submucosa.
-
Service type: Endoscopic submucosal injection
-
Typical site of service: Ambulatory surgical center or hospital outpatient department; may also occur in endoscopy suites configured for upper gastrointestinal procedures
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents to the outpatient endoscopy suite with symptomatic esophageal submucosal lesions and focal bleeding at the gastroesophageal junction refractory to conservative therapy. After pre-procedure evaluation, including history, medication review (anticoagulant management), and informed consent, the patient is prepared for a diagnostic and therapeutic esophagogastroduodenoscopy (EGD) using a flexible endoscope. Under monitored anesthesia care or moderate sedation, the endoscope is inserted through the mouth into the esophagus. The provider identifies the target area and performs one or more submucosal injections (for example, saline with epinephrine, saline with dye, or a submucosal lifting solution) to raise the mucosa for lesion resection, to control localized bleeding, or to create a cushion for subsequent endoscopic mucosal resection (EMR). Post-procedure, the patient is observed in recovery, given discharge instructions, and scheduled for pathology follow-up if tissue was obtained and for routine post- endoscopy care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no specific modifier applies. |
11 | Office or other outpatient visit for evaluation and management |